Washington State University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Washington State University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013501
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Washington State University (WSU) is an educational university that provides educational and research programs. The university offers undergraduate, graduate, professional, international and online courses. It provides educational programs in the areas of agricultural, environmental and natural resource sciences, anthropology, communication, engineering and architecture, nursing, veterinary science and geology among others. WSU researchers work with federal and state agencies, national laboratories, business and civic enterprises. It assists in transfer of technology, proprietary information and inventions from WSU laboratories into the marketplace. WSU is headquartered in Pullman, Washington, the US.

Washington State University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Washington State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington State University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Washington State University, Medical Devices Deals, 2011 to YTD 2017 9
Washington State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Washington State University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Botanisol Enters into Collaboration Agreement with Washington State University 11
Cancer Targeted Technology Enters into Research And License option Agreement with Washington State University 12
Licensing Agreements 13
AAVogen Receives Technology from Washington State University 13
Washington State University – Key Competitors 14
Washington State University – Key Employees 15
Washington State University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Government and Public Interest 17
May 15, 2017: WSU researchers deliver first ‘nanotherapeutics’ to tumor 17
Feb 09, 2016: WSU researchers see helpful protein causing cancer 18
Product News 19
Nov 29, 2016: Researchers develop novel wound-healing technology 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Washington State University, Pharmaceuticals & Healthcare, Key Facts 2
Washington State University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Washington State University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Washington State University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Washington State University, Deals By Therapy Area, 2011 to YTD 2017 8
Washington State University, Medical Devices Deals, 2011 to YTD 2017 9
Washington State University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Botanisol Enters into Collaboration Agreement with Washington State University 11
Cancer Targeted Technology Enters into Research And License option Agreement with Washington State University 12
AAVogen Receives Technology from Washington State University 13
Washington State University, Key Competitors 14
Washington State University, Key Employees 15
Washington State University, Subsidiaries 16

★海外企業調査レポート[Washington State University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sompo Japan Nipponkoa Holdings, Inc.:企業の戦略・SWOT・財務情報
    Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sompo Japan Nipponkoa Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Nevada Gold & Casinos, Inc.:企業の戦略・SWOT・財務分析
    Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Daechang Forging Co Ltd
    Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daechang Forging Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Arcus Biosciences Inc (RCUS):製薬・医療:M&Aディール及び事業提携情報
    Summary Arcus Biosciences Inc (Arcus Biosciences) is a clinical stage bio-pharmaceutical company. The company develops and commercializes cancer immunotherapies. Its product pipeline includes AB928, which is in phase 1/1b trial; AB122 is being developed for cancer patients, is in Phase 1 trial; AB15 …
  • Unicaja Banco SA:企業の戦略・SWOT・財務分析
    Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report Summary Unicaja Banco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tokio Marine Asia Pte. Ltd.:企業の戦略・SWOT・財務情報
    Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tokio Marine Asia Pte. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • The McClatchy Company (MNI):企業の財務・戦略的SWOT分析
    The McClatchy Company (MNI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Pearson plc (PSON):企業の財務・戦略的SWOT分析
    Pearson plc (PSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Fulgent Genetics Inc (FLGT):企業の財務・戦略的SWOT分析
    Fulgent Genetics Inc (FLGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SQI Diagnostics Inc (SQD):企業の製品パイプライン分析2018
    Summary SQI Diagnostics Inc (SQI Diagnostics) is a diagnostic company that offers in vitro diagnostic and pharmaceutical research products. The company’s products comprise sqidworks, sqidlite and sqid-X. Its sqidworks system is used in labs. SQI Diagnostic’s sqidlite is a practical benchtop system. …
  • Novavax Inc (NVAX)-製薬・医療分野:企業M&A・提携分析
    Summary Novavax Inc (Novavax) is a clinical-stage biotechnology company that focuses on the discovery, development and commercialization of vaccines to prevent a range of infectious diseases. Its product portfolio includes recombinant nanoparticle vaccines and adjuvants. The company develops vaccine …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • F&C Investment Trust PLC:企業の戦略・SWOT・財務分析
    F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report Summary F&C Investment Trust PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Singapore Power Limited:企業の戦略・SWOT・財務分析
    Singapore Power Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Power Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • gategroup Holding AG:企業の戦略・SWOT・財務分析
    gategroup Holding AG - Strategy, SWOT and Corporate Finance Report Summary gategroup Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Barrick Gold Corporation:企業のM&A・事業提携・投資動向
    Barrick Gold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Barrick Gold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Mylan Laboratories Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Mylan Laboratories Ltd (Mylan), a subsidiary of Mylan NV is a pharmaceutical company that manufactures and supplies API products. The company offers HIV care products for the treatment of HIV/AIDS. It provides women’s care products for therapies such as hormone replacement therapy, infertili …
  • GW Pharmaceuticals Plc (GWP)-製薬・医療分野:企業M&A・提携分析
    Summary GW Pharmaceuticals plc (GW Pharmaceuticals) is a biopharmaceutical company which discovers, develops and commercializes innovative therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, f …
  • Nevro Corp (NVRO):企業の財務・戦略的SWOT分析
    Summary Nevro Corp (Nevro) is a medical device company which focuses on providing novel products that advance the quality of life of people suffering from chronic pain. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacologic neuromodulation platform for the tr …
  • Shell Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Shell Canada Ltd (Shell Canada) a subsidiary of Royal Dutch Shell plc is an integrated oil and gas company that offers upstream and downstream services. The company's upstream services include markets and trades natural gas and power and exploration and extraction of natural gas. Its downstr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆